GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Precigen Inc (FRA:I5X) » Definitions » Shiller PE Ratio

Precigen (FRA:I5X) Shiller PE Ratio : (As of May. 21, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Precigen Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Precigen Shiller PE Ratio Historical Data

The historical data trend for Precigen's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precigen Shiller PE Ratio Chart

Precigen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Precigen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Precigen's Shiller PE Ratio

For the Biotechnology subindustry, Precigen's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Precigen's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Precigen's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Precigen's Shiller PE Ratio falls into.



Precigen Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Precigen's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Precigen's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.092/131.7762*131.7762
=-0.092

Current CPI (Mar. 2024) = 131.7762.

Precigen Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.390 100.560 -0.511
201409 -0.411 100.428 -0.539
201412 0.146 99.070 0.194
201503 0.231 99.621 0.306
201506 -0.330 100.684 -0.432
201509 -0.303 100.392 -0.398
201512 -0.257 99.792 -0.339
201603 -0.494 100.470 -0.648
201606 -0.374 101.688 -0.485
201609 -0.214 101.861 -0.277
201612 -0.351 101.863 -0.454
201703 -0.243 102.862 -0.311
201706 -0.142 103.349 -0.181
201709 -0.277 104.136 -0.351
201712 -0.194 104.011 -0.246
201803 -0.292 105.290 -0.365
201806 -0.437 106.317 -0.542
201809 -0.377 106.507 -0.466
201812 -2.277 105.998 -2.831
201903 -0.354 107.251 -0.435
201906 -0.221 108.070 -0.269
201909 -0.318 108.329 -0.387
201912 -0.981 108.420 -1.192
202003 -0.317 108.902 -0.384
202006 -0.231 108.767 -0.280
202009 -0.153 109.815 -0.184
202012 -0.189 109.897 -0.227
202103 -0.076 111.754 -0.090
202106 -0.083 114.631 -0.095
202109 -0.128 115.734 -0.146
202112 -0.115 117.630 -0.129
202203 -0.091 121.301 -0.099
202206 -0.085 125.017 -0.090
202209 0.444 125.227 0.467
202212 -0.104 125.222 -0.109
202303 -0.093 127.348 -0.096
202306 -0.074 128.729 -0.076
202309 -0.075 129.860 -0.076
202312 -0.119 129.419 -0.121
202403 -0.092 131.776 -0.092

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Precigen  (FRA:I5X) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Precigen Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Precigen's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Precigen (FRA:I5X) Business Description

Traded in Other Exchanges
Address
20374 Seneca Meadows Parkway, Germantown, MD, USA, 20876
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Precigen (FRA:I5X) Headlines

No Headlines